In Vitro Activity and Clinical Outcomes of Clofazimine for Nontuberculous Mycobacteria Pulmonary Disease
Limited data are available regarding the in vitro activity of clofazimine against nontuberculous mycobacteria (NTM) or on outcomes of clofazimine-containing regimens in NTM-pulmonary disease (PD). Therefore, we evaluated the in vitro activity of clofazimine and the clinical outcomes of clofazimine-c...
Main Authors: | Dae Hun Kim, Bo-Guen Kim, Su-Young Kim, Hee Jae Huh, Nam Yong Lee, Won-Jung Koh, Hojoong Kim, O Jung Kwon, Byung Woo Jhun |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/19/4581 |
Similar Items
-
Evaluation of drug susceptibility in nontuberculous mycobacteria using the SLOMYCO and RAPMYCO sensititre plates
by: Natalia Fernandes Garcia Carvalho, et al.
Published: (2021-01-01) -
Epidemiology of Nontuberculous Mycobacteria in Nanjing and MAB_0540 Mutations Associated with Clofazimine Resistance in Mycobacterium abscessus
by: Zhang R, et al.
Published: (2023-05-01) -
A Clofazimine-Containing Regimen Confers Improved Treatment Outcomes in Macrophages and in a Murine Model of Chronic Progressive Pulmonary Infection Caused by the Mycobacterium avium Complex
by: Ju Mi Lee, et al.
Published: (2021-01-01) -
Trend of nontuberculous mycobacteria species and minimal inhibitory concentration in a referral laboratory in Korea from 2013 to 2019
by: Young Jin Kim, et al.
Published: (2024-02-01) -
Susceptibility of Selected Multi-Drug Resistant Clinical Isolates to Different Leaf Extracts of Senna alata
by: Ibikunle Ibitayo ANIBIJUWON, et al.
Published: (2018-03-01)